Silo Pharma

Silo Pharma EBITDA per Share

The EBITDA per Share of Silo Pharma (SILO) as of Oct 19, 2026 is -4.82 USD. In the previous year, EBITDA per Share was -15.74 USD — a change of -69.37% (higher).

EBITDA per Share

-4.82USD

YoY

-69.37%

Last updated:

EBITDA per Share of Silo Pharma is 2025 -4.82 USD. EBITDA per Share of Silo Pharma was 2024 -15.74 USD. It decreases by -69.37% higher compared to the previous year.

The Silo Pharma EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
-0.20 USD
Jan 1, 2019
-16.56 USD
Jan 1, 2020
-29.27 USD
Jan 1, 2021
-21.46 USD
Jan 1, 2022
-25.40 USD
Jan 1, 2023
-19.90 USD
Jan 1, 2024
-15.74 USD
Jan 1, 2025
-4.82 USD
The Silo Pharma EBITDA per Share history
YEAREBITDA per ShareYoY
-4.82USD-69.37%
-15.74USD-20.93%
-19.90USD-21.65%
-25.40USD+18.39%
-21.46USD-26.70%
-29.27USD+76.81%
-16.56USD+8,257.81%
-0.20USD-97.19%
-7.04USD+19.67%
-5.88USD+82.62%
-3.22USD-17.27%
-3.89USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Silo Pharma Stock analysis

What does Silo Pharma do? Silo Pharma Inc., based in Englewood Cliffs, US, operates in the Health Care sector as a biotechnology company. It focuses on merging traditional therapeutics with psychedelic research to address conditions like PTSD, Alzheimer's disease, and rare neurological disorders. The company acquires intellectual property from academic institutions, including a research agreement with Columbia University for ketamine-based treatments targeting Alzheimer's and stress-related disorders. Silo Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Silo Pharma stock

EBITDA per Share of Silo Pharma is -4.82 USD in 2025.

EBITDA per Share of Silo Pharma changed from -15.74 USD to -4.82 USD, representing a -69.37% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Silo Pharma since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Silo Pharma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Silo Pharma